Clicky

Thursday, November 5, 2026

Breaking News

Latest SEC filings as they come in

Prudential Jennison Blend Fund Reports Financial Results

Prudential Jennison Blend Fund, Inc. files its latest N-CSR report, showcasing its financial performance and investment strategies for the fiscal year.

Prudential Investment Portfolios 6 Files N-CSR Report

Prudential Investment Portfolios 6 releases its N-CSR report, shedding light on financial performance and investment strategies in the municipal bond sector.

Prudential Jennison Mid-Cap Growth Fund Files Latest N-CSR

Prudential Jennison Mid-Cap Growth Fund, Inc. files its latest N-CSR report, detailing financial performance and investment strategies for stakeholders.

JPMorgan Chase updates performance of Kronos US Equity Index

JPMorgan Chase Financial Co. LLC updates its Kronos US Equity Index performance metrics and risks, impacting investors and the commercial banking sector.

Strider Ventures Fund I, LP Files New Private Offering

Strider Ventures Fund I, LP has filed a new offering under Rule 506(b) to raise capital, highlighting trends in the venture capital industry.

Strategic Advocates LLC Reports $25M in Latest Holdings

Strategic Advocates LLC disclosed over $25 million in holdings, showcasing investments in key companies like AMD and Amazon in its latest SEC filing.

GS Finance Corp. Files Preliminary Pricing Supplement for Notes

GS Finance Corp. has filed a preliminary pricing supplement for notes linked to the S&P 500 Futures Excess Return Index, signaling ongoing innovation.

GS Finance Corp. files $250,000 offering of index-linked notes

GS Finance Corp. has filed a $250,000 offering of S&P 500 Index-Linked Notes due 2028, marking a strategic move in the financial products sector.

Barclays Bank announces new $1.686 million notes offering

Barclays Bank PLC files for $1.686 million in autocallable notes linked to major tech stocks, showcasing innovation in the commercial banking sector.

Phase Change Software amends offering, raises $5.99 million

Phase Change Software LLC has amended its offering, raising approximately $5.99 million of a total $10.04 million goal, reflecting its ongoing funding efforts.

Yellowstone Aviation Capital II files for new private offering

Yellowstone Aviation Capital II, LP has filed a new offering under Rule 506(b), signaling a move into private investments in the aviation sector.

Robinson Benjamin E III sells shares in World Acceptance Corp

Robinson Benjamin E III has sold shares in World Acceptance Corp, indicating changes in ownership that could impact the personal credit institutions sector.

Grubbs Acquires Shares in UFP Industries, Boosting Holdings

Ronald K. Grubbs Jr. increases his stake in UFP Industries by acquiring shares, reflecting confidence in the company's future.

Grupo TMM SAB Reports Third Quarter 2026 Financial Results

Grupo TMM SAB announces financial results for Q3 2026, showing recovery in maritime operations and plans for service diversification.

Dropbox CFO sells 2,055 shares under trading plan

Sarah Elizabeth Schubach, Dropbox's CFO, sold 2,055 shares of Class A stock, reflecting her financial strategy under a Rule 10b5-1 trading plan.

BofA Finance LLC files pricing supplement for new notes

BofA Finance LLC has filed a pricing supplement for Auto-Callable Notes linked to major stock indices, enhancing its product offerings.

BofA Finance LLC announces new yield notes offering

BofA Finance LLC files a pricing supplement for Callable Yield Notes linked to major indices, guaranteed by Bank of America Corporation.

Morgan Stanley Finance LLC Files Pricing Supplement for Notes

Morgan Stanley Finance LLC files a pricing supplement for market-linked notes due November 4, 2030, reflecting its strategy in the competitive financial sector.

Mohawk Industries Director Files to Sell Shares of Stock

Jeffrey Lorberbaum of Mohawk Industries has filed to sell 1,646 shares of common stock, indicating potential shifts in ownership dynamics.

Carr Douglas Files Form 144 to Sell Shares of Century Therapeutics

Carr Douglas has filed a Form 144 to sell 266 shares of Century Therapeutics, reflecting ongoing activity in the biotechnology sector.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →